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Abstract The aim was to compare the protein release
from normal human osteoblasts (NHO) cultured on scaf-
folds with similar morphology but different coatings. Dif-
ferent ceramic coatings; TiO2, SiO2 and calcium phosphate
(CaP); Ca9HPO4(PO4)5OH, were applied to porous TiO2
scaffolds prepared by polymer sponge replication. NHO
were cultured on scaffolds in triplicates. The concentration
of cytokines and Ca2?, and alkaline phosphatase (ALP)
activity in the cell media was quantified. The secretion of
osteopontin, osteoprotegerin, vascular endothelial growth
factor and interleukin-6 was higher from NHO on TiO2
compared to SiO2 and CaP. The secretion from cells on the
three scaffolds was, however, either similar or lower than
the control cells cultured on plastic. The Ca2? concentra-
tion was higher in cell media on CaP the first week, and no
difference in ALP activity was observed. TiO2 coating
induced a higher secretion of factors indicating enhanced
osteoblast differentiation as compared to CaP and SiO2.
1 Introduction
Autologous bone grafts have long been considered the
‘gold standard’ for reconstruction of bone due to
immunological feasibility and osteoinductive properties
[1]. Disadvantages of grafting with autologous bone may
be limited supply of bone suitable for harvest and potential
donor site morbidity [2]. These factors have led to alter-
native approaches of bone substitute grafting.
A scaffold for bone repair must be biocompatible. In
addition, it must have osteoconductive properties, prefer-
ably with a structure mimicking trabecular bone. Further
the scaffold must provide immediate physical support in
order to prevent collapse of the bony defect due to potential
high loads to the reconstructed site [3, 4]. It is important
that the scaffolds are porous and provide a high intercon-
nectivity in order to facilitate angiogenesis, osteoblast
ingrowth and attachment [3, 5]. Various synthetic bone
graft materials have been developed to fulfill these criteria
in order to serve as a scaffold to promote proliferation of
host osteoblasts and bone growth.
Calcium phosphates (CaP), hydroxyapatite (HA) and
b-tricalcium phosphate (b-TCP) in particular, have been
extensively researched and widely used for bone repair as it
represents the main inorganic constituent in hard tissues and
possesses osteoconductive properties [6]. Further, certain
types of calcium phosphates have demonstrated osteoin-
ductive properties [7, 8], although these mechanisms are
unclear [6]. Bioactive glasses represent another type of
biomaterial with osteoinductive properties [9], and a porous
Bioglass scaffold for bone repair has recently been devel-
oped [10]. However, common for calcium phosphates and
bioactive glasses is low compressive strength in scaffolds
designed with the porosity and interconnectivity required for
bone ingrowth [10–13]. These mechanical limitations may
impede scaffold use for bone repair in load bearing sites.
Titanium dioxide (TiO2) is a biocompatible material
reported to have bioactive properties [14, 15]. In addition,
the TiO2 scaffolds have demonstrated compressive strength
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sufficient for placement in moderately mechanically loaded
bone [16], and the authors hypothesized that the TiO2
scaffold may perform well in clinical use.
Sabetrasekh and co-workers [17] compared a TiO2 scaf-
fold to commercially available bone graft materials of natural
and synthetic origin CaP, and titanium, and demonstrated
different effects on cell viability and proliferation. However,
the morphology of the tested graft materials in this study
varied considerably and may be responsible for the variation
in biological response. Few studies have compared similar
morphology with different surface chemistry.
Therefore, the aim of the study was to compare the
effect of SiO2 or CaP coatings with TiO2 on primary
human osteoblasts in scaffolds of similar pore morphology.
2 Materials and Methods
2.1 Scaffold Production
Ceramic TiO2 scaffolds were fabricated by a replication pro-
cess [16]. In brief, TiO2 slurry was prepared by dispersing 65 g
of TiO2 powder (Kronos 1171, Kronos Titan GmbH, Lever-
kusen, Germany) in 25 ml sterilised H2O and the pH of the
dispersion was kept at 1.5 for the entire duration of the stirring
with small additions of 1 M HCl. The slurry was stirred
(Dispermat CA-40, VMA-Getzmann GmbH, Germany) for
2.5 h at 5,000 rpm. Cylindrical polyurethane foam templates,
17 mm in diameter and 3.75 mm in height (60 ppi, Bulbren S,
Eurofoam GmbH, Wiesbaden, Germany), were coated with
the prepared slurry. Prior to sintering in 1,500 C for 40 h, the
polymer template was carefully burnt out of the green body at a
lower temperature. 90 scaffolds were produced in total and
divided into three groups of 30 scaffolds each. The final
dimensions of the scaffolds were approximately 13.5 mm in
diameter and 3 mm in height due to the shrinkage during the
sintering phase. After relevant recoating procedures, all scaf-
fold samples were steam sterilised in 121 C for 20 min.
2.1.1 TiO2
Sintered scaffolds were recoated with TiO2 slurry prepared
using the previously described procedure, only this time
mixing 40 g of TiO2 powder with 25 ml of water. Excess
slurry was removed from the scaffold structure by centri-
fugation (1 min at 1,500 rpm; Biofuge 22R Heraeus Sep-
atech, Osterode, Germany). The recoated scaffolds were
then sintered in 1,500 C for 40 h.
2.1.2 SiO2
SiO2 slurry was prepared by dispersing 12 g of micro-
crystalline SiO2 powder (Sigma-Aldrich, Steinheim,
Germany) in 25 ml sterilised H2O and stirred (Dispermat
CA-40) for 2.5 h at 2,500 rpm. TiO2 scaffolds were coated
with SiO2 by immersing the scaffolds in the prepared
slurry. Excess slurry was centrifuged (1 min at 1,500 rpm;
Biofuge 22R Heraeus Sepatech) out of the TiO2 foam
templates to ensure that only a thin layer of slurry covered
the scaffold struts without blocking the pores. The SiO2
coating layer was dried in 60 C for 5 h and then heat
treated at 1,200 C for 5 h (LHT 02/17 LBR, Nabertherm
GmbH, Lilienthal, Germany), the heating and cooling rates
were set at 2.5 C/min. The coating and heat treatment
procedures were repeated once to apply two coating layers.
2.1.3 CaP
Calcium phosphate (CaP) coating was produced using sol–
gel method [18]. 3 M triethyl phosphite (C2H5O3PO;
Sigma-Aldrich, Pittsburgh, PA, USA) dissolved in anhy-
drous ethanol was hydrolysed for 24 h with fixed amount
of deionised water (the molar ratio between water and
phosphite was fixed at 4:1) in a parafilm-sealed glass
container under vigorous stirring. A stoichiometric amount
of 3 M calcium nitrate (Ca(NO3)294H2O; Sigma-Aldrich)
dissolved in anhydrous ethanol was added dropwise to the
hydrolysed phosphite colloidal solution (sol) (Ca-to-P ratio
fixed at 1.67:1). The mixed sol solution was then contin-
uously agitated for additional 10 min and subsequently
aged for 24 h at room temperature. TiO2 scaffolds were dip
coated with the prepared CaP sol, and excess sol was
removed from the scaffolds by blowing pressurised air
through the coated scaffolds to ensure that only a thin layer
of sol covered the scaffold struts without blocking the
pores. The CaP coating layer was dried in 80 C for 10 h
and then heat treated at 1,000 C for 1 h (LHT 02/17
LBR), the heating and cooling rates were set at 2 C/min.
The dip coating and heat treatment procedures were repe-
ated twice to apply three coating layers. For the purpose of
XRD analysis, TiO2 ceramic discs were dip coated in
prepared CaP sol. The TiO2 discs were prepared using the




The initial visualisation and optical observation of the pore
structure of the prepared scaffolds were performed using a
scanning electron microscope (SEM) (TM-1000, Hitachi
High-Technologies, Tokyo, Japan), and a desktop 1172
micro-computed tomography imaging system (micro-CT)
(Skyscan, Kontich, Belgium) was used to determine the
three-dimensional microstructure and porosity of the
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scaffolds. All scans were performed with a voxel resolution
of 8 lm. Otherwise all scanning and reconstruction
(Nrecon, Skyscan) settings were performed as previously
reported [16]. In order to eliminate potential edge effects, a
cylindrical volume of interest (VOI) with a diameter of
8 mm and a height of 1.5 mm was selected in the centre of
the scaffold. Pore architectural parameters were determined
using the 3D analysis function in the standard Skyscan
software (CTan, SkyScan).
2.2.2 Chemical Surface Composition of Scaffolds
The chemical compositions of the scaffold surfaces were
investigated with energy-dispersive X-ray spectroscopy
(EDX) using Quanta 200 FEG SEM (FEI, Denver, USA)
equipped with EDX detector (EDAX, USA). The samples
were scanned at environmental SEM mode with 15 kV
acceleration voltage and 50 s acquisition time. The EDAX
detector had a resolution of 132 eV.
X-ray diffraction (XRD) was used for additional
chemical analysis of the CaP coating. XRD analysis was
performed with D8 Discover powder diffractometer with a
Ge (111) monochromator providing CuKa1 radiation and
LynxEye detector (Bruker, Karlsruhe, Germany). The
acquisition was done using h - 2h configurations.
2.2.3 Compressive Strength
The mechanical strength was investigated in a compressive
test (Zwicki, ZwickRoell, Ulm, Germany). The compres-
sion tests were performed in accordance with DIN EN ISO
3386 at room temperature using a load cell of 1 kN with
preloading force set to be 0.5 N. The scaffolds were
compressed along their long axes at a compression speed of
100 mm/min until failure. The force and displacement
were recorded throughout the compression and converted
to stress and strain based on the initial scaffold dimensions.
2.3 Cell Culture
The utilized cells were commercially available normal
human osteoblasts (NHO) of two different donors (Camb-
rex Bio Science, Walkersville, MD, USA) from tibia and
femur, respectively. The cells were grown in osteoblast
growth media (OGM; Cambrex Bio Science), and the
media was changed three times per week until confluence.
At the time of scaffold seeding, the NHO from tibia had
reached passage 5 and the NHO from femur had reached
passage 6. The scaffolds were placed in 24-well plates
(Multidish, Nuncleon Surface, Nunc., Roskilde, Denmark).
Triplicate of empty plastic wells served as untreated controls
and triplicates of each scaffold were harvested at each time
point.
The cells were seeded from a uniform solution in a
dropwise manner (0.5 ml containing 18–25 9 103 cells)
onto each scaffold. Further 0.5 ml of cell medium only was
added to the wells after cell adhesion to ensure that all
scaffolds were fully soaked. From this time the media was
changed twice a week throughout the experiment.
At day 1, 7, 14, 21, 28, 35 and 42 cell culture media
was sampled, and stored at -20 C until analysis. At day
1, 14, 21, 28 and 42 the wells were washed in PBS prior
to fixation in phosphate buffered formalin with a pH of
7.4.
2.4 Histological Analysis
The wells were immersed in an ascending alcohol solution
prior to plastic embedding with a light-curing methacrylate
resin (Technovit 7200 VLC, Heraeus Kulzer GmbH,
Wehrheim, Germany). Slices containing parts of the
cylindrical scaffolds were cut in either a vertical or hori-
zontal direction using an Exakt saw (Exakt, Norderstedt,
Germany). For the empty plastic wells, care was taken to
include the well floor in the section. The histological sec-
tions were prepared according to the cutting-grinding
technique previously described [19, 20]. The sections were
grinded and polished (Polycut-S, Reichert-Jung, Leica
Microsystems, Wetzlar, Switzerland) down to a thickness
of approximately 50 lm and stained with hematoxylin and
eosin, alizarin red or van Gieson. The histological sections
were analysed to assess distribution of osteoblasts and
mineralized nodules.
2.5 Cytokine and Chemokine Levels in Culture
Medium: Immunoassay
Multianalyte profiling was performed using the Luminex
200TM system and the XY Platform (Luminex, Corpora-
tion, Austin, TX, USA). Classification calibration micro-
spheres were purchased from Luminex Corporation.
Acquired fluorescence data were analysed by the 3.1
xPONENT software (Luminex). Prior to analysis, the
samples were concentrated 5 times using Microsep Cen-
trifugal tubes with 3 kDa cut-off (Pall Life Science, Ann
Armor, MI, USA).
The concentrations of cytokines were determined using
the 25-Milliplex Human Cytokine Immunoassay kit (Milli-
pore, Billerica, MA, USA). Further, the level of bone markers
interleukin-1b (IL-1b), interleukin-6 (IL-6), osteoprotegerin
(OPG), osteocalcin (OC), leptin, osteopontin (OPN), para-
thyroid hormone (PTH), tumor necrosis factor-a (TNF-a),
adrenocorticotropic hormone (ACTH), adiponectin and
insulin were determined using Milliplex Human Bone Panel
1B Immunoassay kit (Millipore). All analyses were per-
formed according to the manufacturers’ protocols.
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2.6 Total Protein Content
The total protein content (TP) was quantified with a BCATM
Protein Assay Kit (Pierce Biotechnology, Rockford, IL,
USA) according to the manufacturer’s instructions. The
original cell media sample was diluted 1:5 prior to the
analysis to fit the standard curve. This was determined using
a spectrophotometer (NanoDrop, ND-1000, NanoDrop
Products, Wilmington, DE, USA). 200 lL of the kit working
reagent was added to 25 lL of each diluted sample. The
absorbance was measured at 562 nm in a plate reader (Expert
96, Asys. Hitech GmbH, Eugendorf, Austria).
2.7 Alkaline Phosphatase Activity
Alkaline phosphatase (ALP) activity was quantified by mea-
suring the cleavage of p-nitrophenyl phosphate (pNPP)
(Sigma-Aldrich, St. Louis, MO, USA) into a soluble yellow
end-product that absorbs at 405 nm. A standard curve was
constructed with calf intestinal alkaline phosphatase (Promega,
Madison, WI, USA). 25 lL of media was taken from each
sample and incubated with 100 lL pNPP solution in a 96-well
plate for 30 min in the dark at room temperature. 25 lL of 2 N
NaOH was then added to each well to stop the reaction. The
absorbance was measured in a plate reader (Expert 96).
2.8 Calcium Atomic Absorption Spectrophotometry
The Ca2? concentration in the cell medium was assessed
using a PerkinElmer 2380 flame atomic absorption
spectrophotometer (PerkinElmer, Norwalk, CT, USA).
0.5 ml of a 3.6 % HCl solution was added to the cell
medium and left for incubation with agitation on a plate
shaker for 24 h. The next day a solution of 5 % lanthanum
(LaCl3) and 1 % HCl was added. The spectrophotometer
was calibrated using a calcium concentration standard
curve ranging from 0 to 5 ppm Ca2?, created by the serial
dilution of an atomic absorption calcium standard (Sigma
Diagnostics, St. Louis, MO, USA).
2.9 Statistics
The data obtained by protein analyses and calcium atomic
absorption spectrophotometry was compared between and
within groups using Tukey’s test following a parametric one
way ANOVA. Where the equal variance and/or the normality
test failed, a Kruskal–Wallis one way ANOVA on ranks was
performed (SigmaPlot 12, Systat Software Inc, San Jose,
USA). Mean and standard deviation are presented. A proba-
bility of\0.05 was considered significant.
3 Results
3.1 Scaffold Characterisation
All fabricated scaffolds showed an open and highly inter-
connected pore structure formed by spherical macropores,
the average size of which exceeded 400 lm (Fig. 1). The
average porosity of the scaffolds was 92 ± 2 % (n = 6)
Fig. 1 Comparison of pore structure and surface morphology of the different scaffold groups
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and pore network showed over 95 % interconnectivity
through connections as large as 160 lm. The volumetric
scaffold parameters are listed in Table 1.
The thickness of the coating layer was estimated from
SEM images to be approximately 1–3 lm for both CaP and
SiO2 coatings, and thus was not considered to affect the
overall porosity or the pore architectural parameters, such
as pore size, surface area-to-volume ratio, and intercon-
nectivity. However, some closed pore walls were seen
close to the bottom edge on some of the SiO2 scaffolds.
Due to limited thickness of the coating layer and the more
radiolucent nature of CaP and SiO2 coatings in comparison
to TiO2 bulk material, the coating layers were scarcely
visible in micro-CT images.
While the pore structure of the scaffolds from the three
different groups was regarded similar to each other, the
scaffolds differed greatly in their surface properties. Typ-
ical surface morphologies of each of the three scaffold
groups are presented in Fig. 1. The EDX analysis of the
scaffold surfaces revealed that the surface of the TiO2
scaffolds consisted of titanium and oxygen (Ti: 52 weight
percentage (wt%), O: 46 wt%) with a small amount of
aluminum impurities (2 wt%), while only silicon and
oxygen was detected on the surface of SiO2 coated scaf-
folds (Si: 48 wt%, O: 52 wt%). XRD pattern of the CaP
coating revealed the chemical composition of the coating to
match with calcium hydrogen phosphate hydroxide
(Ca9HPO4(PO4)5OH) as shown in Fig. 2.
The TiO2 coated scaffolds had the highest compressive
strength. The compressive strength test results are listed in
Table 2.
3.2 Histology
Several hundred sections were made in total, representing
all harvest time points, all groups and both donors. Dis-
appointingly, no mineralized nodules could be observed,
and osteoblasts were scarce and only occasionally visible.
The histological analysis was thus excluded from the
study.
3.3 Enhanced Secretion of OPN and OPG
from Cells on TiO2
The level of IL-1b, PTH, TNF-a, ACTH, adiponectin and
insulin were all below reliable detection and the level of
leptin was detected in the femur donor only.
The secretion of leptin was similar for all treatment
groups until day 42 where the secretion from cells on TiO2
were higher than on CaP and SiO2 (P = 0.016, P = 0.015,
respectively). No difference was observed at any time point
between TiO2 and plastic (data not shown).
There were no differences in the secretion of OC from
cell cultures in the different scaffolds (data not shown).
The secretion of OPN from both tibia and femur oste-
oblasts were higher on TiO2 than from those on CaP and
SiO2 at day 7 (P = 0.013, P = 0.043 and P \ 0.001,
P = 0.001, respectively), day 14 (P \ 0.001, P = 0.002
and P = 0.003, P = 0.014, respectively), day 21 (P =
0.003, P = 0.008 and P \ 0.001, P = 0.012, respectively),
and in the femur donor only at day 28 (P \ 0.001,
P = 0.001, respectively) and at day 42 (both P \ 0.001)
(Fig. 3).
Cells on CaP had no change in the secretion of OPN,
and was significantly lower than the secretion from cells on
SiO2 in femur at day 28 (P = 0.046).
Table 1 Volumetric parameters (mean ± standard deviation) of the
microCT morphological analysis for scaffolds coated with TiO2
(n = 6)
Parameter Unit Mean SD
Porosity % 91.66 1.82
Surface area-to-volume ratio l/mm 54.57 6.84
Pore size lm 440.36 12.84
Strut thickness lm 64.73 5.93
Intersection surface mm2 9.54 2.24
Interconnectivity \160 lm % 95.81 1.09
Fig. 2 XRD pattern of the CaP coating. Chemical composition of the
coating identified the CaP as calcium hydrogen phosphate hydroxide.
Rutile (TiO2) (times) and Ca9HPO4(PO4)5OH (plus)
Table 2 Compressive strength (mean ± standard deviation) (n = 5)
Coating Unit Mean SD
TiO2 MPa 1.43 0.11
SiO2 MPa 0.34 0.06
CaP MPa 0.25 0.03
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The secretion of OPN from osteoblasts, both from tibia
and femur, was enhanced on plastic during the study period
(day 1; 0.32 ± 0.09 ng/ml and 0.31 ± 0.06 ng/ml, respec-
tively, day 7; 1.54 ± 0.34 ng/ml and 1.1 ± 0.07 ng/ml,
respectively, and day 14; 2.38 ± 0.25 ng/ml and 1.2 ±
0.08 ng/ml, respectively). The secretion of OPN from cells
on TiO2, however, was lower than the secretion from control
cells at day 7 (P = 0.003 and P \ 0.001, for tibia and femur
osteoblasts, respectively), day 14 (P \ 0.001 and P = 0.02,
respectively), and day 28 (P = 0.034) in the femur donor
only. After day 28 there is no significant difference between
the secretions from cells on plastic compared to TiO2.
The concentration of OPG was enhanced in all groups
(Fig. 3). The secretion of OPG from tibia osteoblasts on
TiO2 was higher than from cells on SiO2 at day 7
(P = 0.017) and day 14 (P = 0.008), and the secretion
from femur osteoblasts on TiO2 was higher than from cells
on CaP and SiO2 at day 14 (P = 0.023 and P = 0.025,
respectively), day 21 (P = 0.001 and P = 0.039, respec-
tively), and at day 28 compared to CaP only (P = 0.007).
On plastic, the OPG secretion from tibia and femur oste-
oblasts were 0.22 ± 0.001 and 0.32 ± 0.01 ng/ml,
respectively, at day 1, and 1.78 ± 0.36 and 1.11 ±
0.04 ng/ml, respectively, at day 7. The secretion of OPG on
plastic, however, was significantly higher than TiO2 only in
the femur donor at day 1 (P \ 0.001).
3.4 Enhanced Secretion of IL-6 and Rantes from Cells
on TiO2
The secretion of IL-6 from tibia osteoblasts on TiO2 was
higher than from cells on CaP (P \ 0.001) and SiO2
(P \ 0.001) at day 28 only. The secretion of IL-6 from
femur osteoblasts was higher compared to from cells on
CaP at day 21 (P = 0.003) (Fig. 4).
The secretion of IL-6 was enhanced from both tibia and
femur osteoblasts on plastic (day 1; 224 ± 18 and 274 ±
34 pg/ml, respectively, day 7; 378 ± 61 and 403 ±
83 pg/ml, respectively, and day 14; 545 ± 135 and
560 ± 0 pg/ml, respectively). The IL-6 secretion from cells
on plastic was higher than the secretion on TiO2 in cells of
tibia origin only at day 21 (P = 0.003) and day 28
(P \ 0.001).
There were no differences in the secretion of IL-4 from
cells on TiO2 and CaP. In comparison the secretion from tibia
and femur osteoblasts on SiO2 were notably lower than on
both TiO2 and CaP the first 14 days (day 1; P = 0.002,
P = 0.002 and P = 0.009, P = 0.023, respectively, day 7;
P \ 0.001 for all, and day 14, P \ 0.001, P \ 0.001 and
P = 0.024, P = 0.006, respectively) (Fig. 4). There were no
significant difference in the secretion from cells on TiO2 and
plastic. A similar pattern of secretion was observed for IL-8,
with no differences between cells cultured on plastic, TiO2 or
CaP, but a reduced secreted level from cells on SiO2 the first
time points (data not shown).
The secretion of RANTES was enhanced from both tibia
and femur osteoblasts on TiO2 from day 1; 0.6 ± 0.04 and
1.4 ± 0.6 pg/ml, respectively, to day 42; 3.1 ± 0.6 and
10.5 ± 4 pg/ml, respectively (Fig. 4). The secretion of
RANTES from tibia osteoblasts was higher on TiO2 than
from cells on SiO2 at day 7 (P = 0.004), and both CaP and
SiO2 at day 14 (P = 0.002, P = 0.022, respectively).
Femur osteoblasts secreted higher levels on TiO2 compared
to CaP and SiO2 at day 21 only (P = 0.006, P = 0.021,
Fig. 3 The mean concentration
(ng/ml) of OPN and OPG in cell
culture media from primary
human osteoblasts from tibia
(left column) and femur (right
column) at each time point
(days). The error bars represent
the standard deviation of the
mean (n = 3).
CaP = Ca9HPO4(PO4)5OH
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respectively). No difference was observed at any time point
in either donor comparing TiO2 and plastic.
3.5 Angiogenic Markers
The secreted levels of MCP-1 were higher from cells on
TiO2 and SiO2 compared to from cells on CaP (Fig. 5).
However, the difference was not significant for other time
points than day 28 in the tibia donor (TiO2: P \ 0.001 and
SiO2: P \ 0.001).
The secretion of MCP-1 was enhanced for cells in both
the tibia and femur donor on plastic (from day 1;
0.25 ± 0.01 and 0.7 ± 0.02 ng/ml, respectively, to day 7;
0.9 ± 0.01 and 1.1 ± 0.02 ng/ml, respectively). The MCP-1
secretion from cells on plastic was similar to that of cells on
TiO2, and a difference was observed at day 1 in the femur
donor only (P = 0.008).
The secretion of VEGF was enhanced from femur osteo-
blasts on TiO2 from day 1; 0.03 ± 0.01, to day 42;
0.6 ± 0.08 ng/ml (Fig. 5), and secretion was higher than from
cells on SiO2 at day 7 (P = 0.045), CaP at day 14 (P = 0.028),
CaP and SiO2 at day 21 (P \ 0.001, P \ 0.001, respectively),
day 28 (P \ 0.001, P = 0.004, respectively) and day 42
(P \ 0.001, P \ 0.001, respectively). No significant
differences were observed in the tibia donor and no difference
was observed at any time point for either donor between TiO2
and plastic.
3.6 Alkaline Phosphatase
The ALP activity of day 1 was similar to that of day 42 for
all groups in both donors, and ALP was secreted in a
steady-state throughout the 6 weeks on all scaffolds and
plastic (data not shown).
3.7 Total Protein Content
There was no difference in TP secretion among groups in either
donor. Osteoblasts from tibia demonstrated a threefold
increase of the TP concentration from day 1 to the end of the
experiment, whereas osteoblasts from femur displayed a minor
increase only. Plastic did not exhibit any difference compared
to the test groups at any time in either donor (data not shown).
3.8 Ca2?
The secretion of Ca2? was not altered in cells from either
the tibia or femur donor on plastic, TiO2 or SiO2 (data not
Fig. 4 The mean concentration
(pg/ml) of IL-6, IL-4 and
RANTES in cell culture media
from primary human osteoblasts
from tibia (left column) and
femur (right column) at each
time point (days). The error
bars represent the standard
deviation of the mean (n = 3).
CaP = Ca9HPO4(PO4)5OH
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shown). An initial high concentration was, however, found
in the cell culture media from tibia osteoblasts on CaP at
day 1 and 7 (P \ 0.001) compared to all other groups, and
in osteoblasts from femur compared to TiO2, SiO2 and
plastic at day 1 (P = 0.004, P = 0.005, P = 0.004,
respectively) and at day 7 (P \ 0.001, P = 0.003,
P = 0.002, respectively).
4 Discussion
The TiO2 coating induced a higher osteoblast secretion of
OPN, OPG, IL-6, RANTES and VEGF compared to CaP
and SiO2 coatings. The two latter coatings did not induce
significantly higher secretion of any detectable cytokine at
any single time point compared to the TiO2 coated group.
Thus, TiO2 coated scaffolds demonstrated osteoblast
secretion levels closer to the control, although neither
tested coating could display osteoblast secretion higher
than that of the control for any cytokine at any single time
point.
Webster and co-workers [21] compared rat osteoblast
function on discs of TiO2, alumina, hydroxyapatite and
borosilicate. Although the study aimed to evaluate ceramic
grain size, nanophase TiO2 induced higher levels of ALP
and Ca2? compared to hydroxyapatite and borosilicate.
The cell density was similar on TiO2 and hydroxyapatite at
5 days, both higher than borosilicate, whereas the cells
were more spread on borosilicate compared to TiO2 and
hydroxyapatite.
The results suggested that nanophase TiO2 support rat
osteoblast differentiation better than borosilicate and
hydroxyapatite. Similarly, TiO2 supported higher secretion
of osteoblastic markers compared to calcium phosphate
and silica in the present study. Although no differences
were observed in ALP activity and the Ca2? release only
differed the first week, the level of other markers suggested
enhanced osteoblast differentiation. Regarding cell prolif-
eration, Webster and co-workers [21] found higher cell
density in the TiO2 and hydroxyapatite groups compared to
the borosilicate control at day 3 and 5. In the present study
no difference in total protein content was observed. How-
ever, these methods of evaluating cell proliferation vary
considerably, and may not be comparable. Detection of
significant differences in the total protein content in cell
media consisting of foetal calf serum require great varia-
tion, especially if the cell number is low.
Sabetrasekh et al. [17] evaluated cell proliferation using
human mesenchymal stem cells cultured on TiO2 granules
and compared it to other bone graft substitute granules, one
consisting of hydroxyapatite and one of hydroxyapatite and
b-tricalcium phosphate in a 60:40 ratio. The cell number
was significantly higher on TiO2 compared to the calcium
phosphates at both day 1 and day 3. Again the cell pro-
liferation methodology may not be compared to the present
study. The results of these studies suggest that other anal-
yses should be employed in further research to detect sig-
nificant differences in cell proliferation.
Although the porosity and interconnectivity was similar
across the differently coated scaffolds, the surface rough-
ness was different for the three coatings (Fig. 1). It has
been demonstrated that cell differentiation is sensitive to
both micro- and submicroscale surface roughness, and
increased roughness is associated with enhanced osteoblast
differentiation and local factor production in vitro [22, 23].
Thus, other than the chemistry of the coating material, the
Fig. 5 The mean concentration
(pg/ml) of MCP-1 and VEGF in
cell culture media from primary
human osteoblasts from tibia
(left column) and femur (right
column) at each time point
(days). The error bars represent
the standard deviation of the
mean (n = 3).
CaP = Ca9HPO4(PO4)5OH
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difference in surface roughness may therefore have attrib-
uted to the results. However, the TiO2 coated scaffolds had
the smoothest surface, yet higher secretion, suggesting that
the chemistry of the coating materials indeed had signifi-
cant impact.
The XRD analysis demonstrated the CaP material to be
Ca9HPO4(PO4)5OH, known as calcium-deficient hydroxy-
apatite. This material has been described previously, and
has been reported to have properties comparable to b-tri-
calcium phosphate with regard to osteogenic induction
[24]. CaP demonstrated higher concentrations of Ca2? ions
at the first two time points in both donors. This was
probably due to passive dissolution of Ca2? ions from the
CaP material the first week, which has been reported pre-
viously [25, 26]. As the cells on CaP coated scaffolds
reached the steady-state concentration of Ca2? ions
observed in the other groups by day 14, this may suggest
that by then the dissolution had reached equilibrium. The
dissolution of calcium did not, however, seem to enhance
expression of osteoblastic markers as previously suggested
[27, 28].
The histological analysis did not contribute to any
results. However, the absence of mineralized nodules was
in agreement with the non-detectable changes in the con-
centrations of OC, Ca2? and ALP activity, indicating that
mineralization did not take place. Alizarin red and van
Gieson staining were also performed as the hematoxylin
and eosin stain did not render measurable results, but with
the same outcome. The histological analysis suggests there
may have been too few cells in the experiment. A three-
dimensional scaffold may necessitate a higher quantity of
cells in order to observe proper mineralization. The lack of
mineralized nodules observed on plastic may further sug-
gest a low cell number. The chosen methodology of plastic
embedding and grinding prior to histological analysis may
not have been appropriate for the in vitro experiment
performed.
Zhou and co-workers [29] found that a small seeding
density of human alveolar osteoblasts on mPCL-TCP
scaffolds could support cell attachment and proliferation,
secretion of OC and ALP, as well as extracellular matrix
synthesis. Further, the authors observed that seeding at
higher densities did not influence the extent of cell prolif-
eration and tissue formation over time. However, the
lowest cell density tested in that study was 5 9 104 million
cells per scaffold, utilizing a scaffold size of 3 9 3 9
5 mm2. The cell density in the present study was in com-
parison 1.8–2.5 9 104 million, cultured on considerably
larger scaffolds of 13.5 mm in diameter and 3 mm in
height. This may suggest that the cell density was too small
for a large three-dimensional substrate in order to achieve
significant variation in OC and ALP levels, and histologi-
cally detectable mineralization. On the other hand,
osteoblasts cultured on plastic did render similar results as
the test groups, despite the lower total surface area. As
mineralization was not evident in any scaffold or on plas-
tic, it is tempting to suggest that the results would have
been different with a higher cell seeding number. In the
present study a static culture condition was employed. A
dynamic culture condition in combination with a higher
cell seeding number may further modify the outcome. This
has previously been reported to improve cell invasion and
cellular attachment inside plastic and titanium scaffolds
[30, 31], but will have to be confirmed by further in vitro
experiments.
5 Conclusions
A higher secretion of bone markers (OPN, OPG), immune
modulators (IL-6, RANTES) and angiogenic markers
(VEGF) indicate that TiO2 support osteoblast growth and
bone remodeling better than CaP and SiO2. This study
demonstrates that TiO2 scaffolds are able to induce human
osteoblast differentiation in vitro, suggesting its potential
as a scaffold for hard tissue repair.
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